Objectives: The purpose of the study was to determine the omega-3/omega-6 ratio in swine brain homogenate by HPLC with UV detection and to discuss the values obtained by comparison to the human species. Materials and methods: Determinations were performed by HPLC method using as mobile phase an isocratic mixture (A:B -5:95) of mobile phase A = 25% acetonitrile in water and B = acetonitrile with a flow-rate of 1.2 mL/min and UV detection at 205nm. Chromatographic column: Phenomenex C8 150x4.6 mm 5μm. 50 g swine brain was hydrolyzed with 100 mL 0.5N HCl, the organic phase was extracted in 50 mL hexane, concentrated by evaporation and resumed in 200 μL acetonitrile. Results: Polyunsaturated fatty acids were separated as follows arachidonic acid (AA) -Rt = 2.69 min, docosahexaenoic acid (DHA) -Rt = 3.12 min and eicosapentaenoic acid (EPA) -Rt = 3.97 min. The following omega-3/omega-6 ratios were calculated (DHA + EPA)/ AA = 0.572 ± 0.451, EPA/AA = 0.027 ± 0.015 and DHA/AA = 0.689 ± 0.612. Conclusions: The values obtained for these ratios should be balanced, but in reality they are in favor of the ratio denominator. Considering the physiological and nutritional similarities and that an accurate diagnosis of neurodegenerative disease is set in post-mortem, swine brain homogenate could serve as an animal model for human nervous tissue.
Introduction
In the past a high-fat food intake responsible for the increase of serum triglycerides and cholesterol was considered a cardiovascular risk factor, such as in the Framingham score, but nowadays the type of ingested fat is more important. Unsaturated fats are preferred to saturate and polyunsaturated fatty acids (PUFA) are considered cardioprotective factors [1] .
World Health Organization (WHO) in 2009 in "Global Strategy on Diet, Physical Activity and Health" considered that a diet rich in long-chain omega-3 fatty acids (n-3PUFA) could be beneficial in non-communicable disease prevention such as neurological and neurodegenerative diseases, cancer, cardiovascular disease and diabetes [2] .
Literature data show that omega-3 polyunsaturated fatty acids (n-3PUFA), particularly EPA and DHA, are involved in reducing the risk of cardiovascular diseases or metabolic syndrome often a cause of neurodegenerative diseases, of Alzheimer's disease by multiple mechanisms. One such mechanism would be reducing atherogenic risk by reducing "de novo" biosynthesis of triglycerides or LDL cholesterol particle size growth [3] .
It is well known that the incorporation of n-3PUFA into membrane phospholipids depends on plasma levels and therefore on food intake [4] . Determination of plasma levels of n-3PUFA reflects the situation in the moment of analisis (food intake in the last 4-5 hours or different causes of lipolysis) and the turn-over of free fatty acids in plasma is rapid. Omega-3 Index (n-3PUFA percentage in red blood cells (RBC) membrane phospholipids) may be a better indicator of the overall situation and is considered an independent biomarker of sudden cardiac death risk [5] .
Methods of gas chromatography (GC) [6] , LC/MS [7] or HPLC with UV detection [8] are described in literature to determine PUFA from biological samples.
The purpose of this study is to elaborate a HPLC-UV method to identify PUFA (EPA, DHA, AA) in swine brain homogenate and calculation ratios (EPA+DHA)/AA, EPA/ AA or DHA/AA of clinical interest.
Materials and methods

Standards and Reagents
Standard substances were at least 98.0% purity and were purchased as follows EPA and DHA from Cayman Chemical Company and AA from Sigma-Aldrich.
Methanol, acetonitrile, formic acid were HPLC grade and purchased from Merck (Merck KGaA, Darmstadt, Germany).
Preparation of standard solutions
Stock solutions of 1 mg/mL in methanol were prepared and the working solution was obtained by diluting the stock with methanol.
Equipments AB54S (Mettler-Toledo) balance, MP225 (Mettler-Toledo) pH-meter, centrifuge 2-15 (Sigma), mixer 10 (Falc Instruments), Direct Q water purification unit (Millipore), ultrasonic bath Transsonic T700H (Elma).
The chromatographic system
Biological determinations were performed on a Merck Hitachi chromatographic system consisting of: binary pump L-7100 with degasser L-7612; L-7200 automatic injector, L-7360 thermostat and DAD detector L-7455.
Chromatographic column: Phenomenex C8 150x4.6 mm 5μm
The mobile phase. The mobile phase consisted of an isocratic mixture (A : B5 : 95) of mobile phase A= 25% acetonitrile in water and B = acetonitrile with a flow of 1.2 mL/min.
Detection was set at 205 nm.
PUFA Extraction from biological samples
Swine brain was purchased frozen. A quantity of 50 g swine brain was triturated in a mortar with sea sand and left for 12 hours at 70 0 C in a water bath with 100 mL HCL 0.5N. After 12 hours a volume of 100 mL of 5% NaCl was added to reduce the acidity of the sample (dilution with increased ionic strength). The organic phase containing the compounds of interest was extracted in 50 mL hexane, concentrated by evaporation, resumed in 200 μL of acetonitrile and injected into the chromatographic system.
Results
Previously, the optimised separation and detection were investigated. The wavelength for analysis was chosen based on the maximum absorption of the three fatty acids at 205 nm ( Figure 1) . The method permitted a good separation under reversed phase conditions of the three PUFA: AA, DHA and EPA (Figure 1, detail) .
Chromatogram of swine brain homogenate is shown in Figure 2 .
A ballanced ratio n-3PUFA/n-6PUFA provide neuroprotection, while in reality this ratio is slightly unbalanced in favor of n-6PUFA. The values of this ratio are presented in Table I .
Discussions
The results presented in Table I show a n-3PUFA/n-6PU-FA subunitary ratio. In humans, this ratio is probably even more unbalanced considering that swine food contains fishmeal among other things, with increased content of n-3PUFA [9] .
The classic HPLC with UV detection method, for the determination of PUFA without derivatization is limited by the large quantity of utilizied brain samples. Using swine brain homogenate can draw conclusions on the n-3PUFA/n-6PUFA ratio, the results can be extrapolated to humans if we consider similar, omnivorous diets, rich in saturated and monounsaturated fats and low in PUFA of the two species and that human studies are not possible because of ethical considerations [10] .
Recent studies show that the similarities between the two species are not limited to nutrition but also to the gastrointestinal tract anatomy, neuroanatomy, body composition and cardiovascular risk factors: high LDL-cholesterol and low HDL cholesterol, obesity, metabolic syndrome [11] and Omega-3 Index [12] .
DHA is involved in developing of fetal nervous system and retina [1] . Also, after subcutaneous administration in Table I . Relationship between different levels of PUFA in the brain homogenate rats, DHA increases seizure latency in a neuronal excitability model caused by pentetrazol [13] . Recent studies show a possible antipsychotic effect of n-3PUFA. A study comparing antipsychotic effects of n-3PUFA (in a model of psychosis induced by administration of apomorphine, a D 2 -dopamine agonist) with chlorpromazine in rats show that a possible antipsychotic effect of n-3PUFA could be due to the reduction of oxidative stress and the influence on the plasma levels of malondialdehyde and glutathione [14] .
Another study shows that EPA and DHA present similar antidepressants effects of 17β-estradiol by regulating serotonergic neurotransmission and decreasing the synthesis of inflammatory cytokines [15] .
High intake of n-3PUFA influences the insulin/glucagon ratio modified in type 2 diabetes, often a cause of neurodegenerative diseases and cognitive impairments, while, generally, high blood sugar levels are positively associated with risk of Alzheimer's disease [16] .
Another study performed on Streptozotocin induced diabetic rats shows that additional intake of n-3PUFA improves exploratory behavior and memory and prevents secondary neurosensorial impairments caused by diabetes [17] .
The role of the n-3PUFA and especially of DHA in the treatment of spinal cord injury complications is based on reduction of excitotoxicity, inflammation, oxidative stress and lipid peroxidation. DHA increases neuronal survival by unknown mechanisms after spinal cord injury. A possible mechanism would be reducing glutamate toxicity, which is released in large quantities especially after traumatic spinal cord injury [18] .
Another important effect of n-3PUFA is the transformation by cyclooxygenase (COX)-2 and 5-lipoxygenase pathway into resolvin, respectively resolvin series E having EPA as precursor and resolvin series D with DHA as precursor. Resolvin decrease neutrophil migration into inflamed tissues, promotes phagocytosis of apoptotic cells and decrease inflammatory cytokine release [19] .
Neuroprotectins have similar effects to resolvins, but are localized in the brain; literature data show neuroprotective effects and reduce of neuropathic pain in animal models of stroke and Alzheimer's disease [20] .
The content of DHA in the brain is increased. It is found mainly as a component of phospholipids and smaller quantities in the composition of sphingomyelin and ceramide. DHA is released from membrane phospholipids by the catalysis of phospholipase A 2 , it is then hydroxylated by 15-lipoxygenase-1 with the formation neuroprotectin D 1 . Studies show that neuroprotectin D 1 reduces β-amyloid precursor protein converting into 42 amino acid amyloidbeta, reducing therefore characteristic neurodegeneration in Alzheimer's disease [20] .
Conclusion
Based on the physiological similarities, in terms of food intake, values of cardiovascular risk factors LDL/total cholesterol ratio, Omega-3 Index or omega-3/omega-6 ratio and considering ethics regarding the diagnosis of neurodegenerative diseases in human (absence of biochemical biomarkers and presumptive clinical diagnosis) swine could be a highly accessible animal model. Values obtained for the omega-3/omega-6 ratio in swine brain homogenate show that it is unbalanced in favor of the denominator, EPA and DHA deficiency in the brain could be an additional independent risk factor in cognitive impairments.
